policy

Critical planning for regenerative medicine therapies needs to happen now to ensure smooth adoption into health system, paper urges

Data generation, evidence of clinical effectiveness, cost and social values among the key considerations

By |2020-08-13T10:41:28-04:00August 13th, 2020|Categories: News|Tags: , , , , , , |

International workshop tackles key policy questions around the adoption of regenerative medicine therapies

More than 40 academics, clinicians, policy-makers and industry leaders from Canada and the U.K. participated in the Challenges in the Adoption of Regenerative Medicine Therapies (CHART) workshop on June 24 and 25, 2019.

By |2019-11-28T14:44:47-05:00July 2nd, 2019|Categories: News|Tags: , , , , |
Go to Top